|
Dr. Jane Hsiao served as the vice chairman-technical affairs of IVAX from 1995 to January 2006, when Teva acquired IVAX.
Dr. Hsiao served as IVAX’s chief technical officer (CTO) since 1996, and as chairman, CEO, and president of IVAX Animal Health, IVAX’s veterinary products subsidiary, since 1998.
From 1992 until 1995, Dr. Hsiao served as IVAX’s chief regulatory officer and assistant to the chairman. Dr. Hsiao served as chairman and president of DVM Pharmaceuticals from 1998 through 2006.
Dr. Hsiao is a director of Protalix BioTherapeutics, Inc., (PLX-AMEX) a biotech pharmaceutical company; a director of Opko Health, Inc (EXEG.OB-OTC.BB), a biotech pharmaceutical company; and Cellular Technical Services Company, Inc., a provider of products and services for the telecommunications industry. | 